Keros Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $6.5M | 321k | 20.36 |
| 2025-09-30 | $5.3M | 335k | 15.82 |
| 2025-06-30 | $3.5M | 266k | 13.35 |
| 2025-03-31 | $1.3M | 128k | 10.19 |
| 2024-12-31 | $461k | 29k | 15.83 |
| 2022-09-30 | $362k | 9.6k | 37.63 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management